
Shingles vaccine tied to a 20% lower risk of dementia among older people
ADVERTISEMENT
Older adults who got the shingles vaccine may be at significantly lower risk of developing dementia, a new study in Wales has found.
The study, which was
published in the journal Nature
, included about 283,000 older adults who were either deemed eligible or not to receive the shingles jab due to a quirk in Welsh vaccine policy.
In 2013, Wales' government made 79-year-olds eligible for the shingles vaccine, and from then on, people aged into the programme when they turned 79. But due to limited supplies, adults who were 80 or older at the time were never offered the jab.
Researchers from the US, Germany, and Austria homed in on people who turned 80 the week before the vaccine eligibility cutoff and compared them to those who turned 80 the following week.
About half of those who were eligible got the vaccine.
Related
EU regulators block new Alzheimer's drug citing potentially fatal side effects
After seven years, about one in eight people who did not get the vaccine had dementia. But those who got the jab were 20 per cent less likely to be diagnosed, the study found.
The effects were much stronger among women than men.
"It was a really striking finding," Dr Pascal Geldsetzer, the study's senior author and an assistant professor of medicine at Stanford University in the US, said in a statement.
"This huge protective signal was there, any which way you looked at the data".
Other studies have also suggested that the shingles vaccine could help keep dementia at bay.
Last year,
an analysis
published in Nature Medicine showed that people who got a newer version of the shingles vaccine were at significantly lower risk of developing dementia in the six years after they were immunised.
The two vaccines are made differently. The newer, more common jab contains a protein from the varicella zoster virus, which causes both chickenpox and shingles. The vaccine in the Welsh study used a weakened live version of the virus.
Related
Confronting 14 risk factors could delay or prevent nearly half of dementia cases, experts say
In 2023, the UK phased out the live virus vaccine in favor of the newer jab from the drugmaker GSK because it appears to provide protection from shingles over a longer period of time.
People can develop shingles – a painful rash of fluid-filled blisters that can take weeks to clear up – years after getting chickenpox if the dormant virus is reactivated. Older people and those with weakened immune systems are at higher risk.
Both recent studies were natural experiments that are fairly similar to randomised trials, which are the gold standard for medical research. Because of the eligibility criteria for the shingles jab, the researchers were able to compare two otherwise similar groups of people, allowing them to identify the likely impact of vaccination.
ADVERTISEMENT
"What makes the study so powerful is that it's essentially like a randomised trial with a control group – those a little bit too old to be eligible for the vaccine – and an intervention group – those just young enough to be eligible," Geldsetzer said.
Questions remain to prove causation
The studies indicate that regardless of the type of jab, the shingles vaccine could offer some protection against dementia – though more research is needed to prove it.
Related
Experimental drug may slow dementia onset for patients with rare genetic form of Alzheimer's
It also isn't clear what's driving the link. Geldsetzer's team said viruses that affect the nervous system may raise the risk of dementia, but the theory needs to be tested.
Meanwhile, the disparity between women and men might be explained by differences in their immune systems, given they respond differently to infections and vaccinations, according to Dr Maxime Taquet, a clinical lecturer at Oxford University in the UK who led the 2024 study.
ADVERTISEMENT
"Even though this remains kind of hypothetical, we think this is playing a part in why we see a difference in men and women," Taquet told Euronews Health.
To help solidify the evidence, the drugmaker GSK said last week that it is studying data from about 1.4 million older adults in the United Kingdom, some of whom got its shingles vaccine and some of whom did not.
Similarly to the Welsh policy change, in 2023, the UK expanded its shingles vaccination programme from adults 70 and older to adults 65 and up – but those aged 66 to 69 at the time were told they had to wait until they were 70 to get the jab.
Related
Loneliness increases dementia risk by over 30%, new global analysis shows
In another natural experiment, researchers will track whether they develop dementia symptoms.
ADVERTISEMENT
The recent findings on shingles vaccination could represent a new frontier for Alzheimer's research, which for decades has struggled to produce breakthroughs in prevention or new treatments.
Alzheimer's disease is the most common form of dementia, which affects 7 million people in Europe, according to estimates from the European Brain Council.
"Dementia is such a huge burden," Taquet said.
"By triggering the right immune pathways in people, we might be able to reduce or even reverse the dementia process," he added.
ADVERTISEMENT
"There's many, many steps between where we are now and actually getting there, but I think this is an exciting new lead in this area".
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Sustainability Times
a day ago
- Sustainability Times
'NASA Freezes Human Aging': This Stunning Discovery Could Delay Death and Revolutionize Deep Space Survival Forever
IN A NUTSHELL 🚀 Researchers discover that necrosis —a chaotic form of cell death—holds the key to enhancing human aging and space travel. —a chaotic form of cell death—holds the key to enhancing human aging and space travel. 🧬 Unlike programmed cell death, necrosis is messy and contagious , contributing to chronic diseases like Alzheimer's and cardiovascular decline. , contributing to chronic diseases like Alzheimer's and cardiovascular decline. 🔬 Targeting necrosis could unlock new treatments for age-related diseases by breaking destructive cycles and allowing for healthy cell function. 🌌 Addressing necrosis in space could mitigate accelerated aging effects on astronauts, paving the way for longer missions and deeper exploration. In a groundbreaking study, scientists have uncovered the potential role of necrosis in not only understanding human aging but also in enhancing the possibilities of deep space travel. Often dismissed as mere biological debris, necrosis—a chaotic form of unprogrammed cell death—has been revealed as a critical factor in tissue damage and systemic decline. Researchers from University College London, the biotech firm LinkGevity, and the European Space Agency argue that this understanding could pave the way for new treatments for chronic illnesses and provide a crucial tool for humans to survive in space. This discovery opens doors to revolutionary advances in medicine and space exploration. Understanding Necrosis: The Chaotic Cell Death Necrosis is a form of cell death that occurs when cells are overwhelmed by injury, infection, or stress. This process floods cells with calcium, disrupting vital functions and causing the cell to rupture. The collapse spills toxic molecules into the surrounding tissue, triggering inflammation and accelerating damage. Unlike the well-ordered process of programmed cell death, necrosis is messy—and contagious. A single dying cell can spark a chain reaction in its neighbors, compounding degeneration over time. Researchers believe this chaotic process may explain how chronic diseases such as Alzheimer's, kidney failure, and cardiovascular decline intensify with age. According to Dr. Keith Siew, necrosis has been largely overlooked as it was considered an endpoint. However, mounting evidence suggests it is a central mechanism through which systemic degeneration arises and spreads. By targeting necrosis, scientists hope to unlock new ways to treat conditions ranging from kidney failure to cardiac disease, neurodegeneration, and even aging itself. 'Einstein Was Right All Along': This Atomic Clock on the ISS Is Putting General Relativity to Its Ultimate Test Necrosis and Its Impact on Chronic Diseases Dr. Carina Kern emphasizes that necrosis is not just the last stage of cell death but a critical point of convergence across many diseases. In many age-related illnesses—affecting organs such as the lungs, kidneys, liver, brain, and cardiovascular system—relentless cascades of necrosis fuel disease progression. This often occurs alongside impaired healing, leading to fibrosis, inflammation, and damaged cells. Each cascade triggers and amplifies the next, creating a vicious cycle of degeneration. If scientists can target and manage necrosis, they could potentially transform the treatment of various chronic diseases. The key lies in breaking the destructive cycles that necrosis initiates, allowing for healthier cell function and possibly even regeneration. This approach could revolutionize the way we understand and treat degenerative conditions, offering hope for improved health outcomes in aging populations. 'Alien-Like Sea Creature Emerges': Extremely Rare Marine Species Seen for First Time Following 62-Mile Iceberg Detachment Challenges and Opportunities in Space Exploration Necrosis presents a significant obstacle to human space exploration, as astronauts endure accelerated aging caused by microgravity and cosmic radiation. A 2024 study involving Dr. Siew highlighted the rapid deterioration of kidney function in low-gravity environments, raising concerns for long-duration space missions. Professor Damian Bailey suggests that addressing necrosis could transform longevity on Earth and push the frontiers of space exploration. In space, factors that contribute to aging on Earth are exacerbated by cosmic radiation and microgravity, speeding up degeneration dramatically. If necrosis could be prevented, even temporarily, it would shut down destructive cycles at their source, enabling normal physiological processes and cell division to resume. This potential for regeneration could be a game-changer for long-term human survival in space, opening new horizons for exploration and discovery. 'Global Population Far Higher Than Expected': New Revelation Exposes Massive Undercount That Changes Everything About Our Future Future Implications and the Path Forward The study of necrosis and its implications for aging and space travel has been published in Nature Oncogene, signaling a significant step forward in understanding this complex process. The collaborative efforts of scientists from various fields underscore the importance of interdisciplinary research in tackling global challenges. As science continues to unravel the mysteries of necrosis, the potential applications in medicine and space exploration are vast and promising. With the possibility of targeting necrosis to treat chronic diseases and support human survival in space, the future of this research is both exciting and challenging. As we venture further into the unknown, what new discoveries about cell death and regeneration will shape the future of humanity, both on Earth and beyond? Our author used artificial intelligence to enhance this article. Did you like it? 4.6/5 (26)


Euronews
a day ago
- Euronews
At least 12 injured after unknown powder found at German DHL centre
At least a dozen people were injured on Friday after a suspicious package was located at a DHL distribution centre in Langenzenn in southern Germany. Several mail centre employees reportedly came into contact with an unknown white powder through a suspicious package, local media reported. The mail centre staff later complained of feeling ill shortly after the package was discovered, including suffering from rashes. The substance was found on the outside of the parcel and allegedly caused irritation. At least eight people were hospitalised after touching the powder. However, a spokesperson for the regional police said this number could increase. This discovery prompted a response from several emergency departments including police, firefighters and hazardous materials specialists. Around 100 emergency personnel were deployed. A local fire department set up a decontamination site at the scene and the distribution centre was evacuated. The police spokesperson told local media that a so-called decontamination shower had been taken to the warehouse. Such a device can be used to wash off potentially hazardous substances. According to reports, 35 people have already used the shower. Dangerous goods specialists are examining the package, but for now, it is unclear what it contains. Meanwhile, the public has been asked to avoid the area until firefighters give the all-clear. Proposals to allow charging air passengers for carry-on cabin baggage were green-lit by EU transport ministers on Thursday as part of wider reforms of EU air passenger rights, despite resistance from Germany, Portugal, Slovenia and Spain. As Euronews reported, the proposal would create a new free hand luggage item, one that can be slipped under the seat, leaving other stowed cabin bags exposed to charges. The agreed proposals would mean airlines must reroute passengers at the earliest opportunity, including through other carriers or transport modes when appropriate. If rerouting isn't offered within three hours, passengers may book their own travel and claim up to 400% of the original ticket cost in reimbursement. Delays of over four hours on short and intra-EU flights (under 3,500 km) will trigger €300 in compensation. Long-haul flights (over 3,500 km) will warrant €500 after six hours of delay. Airlines would no longer be permitted to invoke "extraordinary circumstances" unless they prove all reasonable measures were taken to avoid disruption. Airlines would also be explicitly required to provide food, drinks, and accommodation during delays. If they fail to do so, passengers may arrange these themselves and claim costs back. To bolster enforcement, the rules impose stricter information requirements. Airlines must clearly inform passengers of their rights at booking and during complaints handling. New timelines are foreseen: passengers would have up to six months to submit a claim, and airlines must respond within 14 days. 'The position finally adopted today answers to an urgent call by air passengers and airlines for up-to-date, clearer and more straightforward rules. The revised rules will bring over 30 new rights to the air passengers, applicable from the moment when they buy a ticket, until they arrive at their destination, and in some cases even beyond. It is a historical milestone as an agreement couldn't have been reached in the last 12 years,' Dariusz Klimczak, Minister of Infrastructure of Poland, whose country holds the presidency of the Council, told reporters. European consumer organisation BEUC criticised the position adopted by member states, saying it 'substantially decreases several key rights'. 'Although the deal improved some rights on paper, giving consumers improved access to information in case of disruption, care and assistance, it represents a substantial rollback of other key rights. Take compensation for instance. The new eligibility thresholds will deprive the majority of passengers from their compensation rights as most delays are between two and four hours,' Agustín Reyna, BEUC's director general, said after the vote. 'Consumer groups have already pointed out that airlines should stop charging passengers for their hand luggage by lodging a complaint with the consumer protection authorities and the European Commission last May. Such practices are contrary to EU rules and EU top court case law which states that hand luggage is an essential aspect of passengers' carriage. On the contrary, the text adopted by the Council legitimises charging for reasonably sized hand luggage,' the director added. The next legislative steps Now it is the turn of the European Parliament to adopt its position on the file. If it does so, the text will enter interinstitutional negotiations with member states, the Parliament and the Commission to find a common position on the new rules. BEUC lamented the fact that the revision is being conducted through an expedited procedure that gives shorter deadlines in the Parliament, which will only need to approve the proposal by an absolute majority.


Euronews
2 days ago
- Euronews
"The green transition and competitiveness are not contradictory," says EU Environment commissioner
Jessika Roswall is convinced that water cannot be taken for granted by Europeans. "We cannot continue like that because extreme weather events have become the new normal in one way," she said in an interview with Euronews as part of a presentation of the new European Water Resilience strategy. Europe is facing a problem of quantity: drought is a problem not only in the south of the continent but also in the north. On the flipside, there have also been severe floods in Valencia and southwest France. "The water scarcity that Europe is facing, the Europe's land, is 30%. So, we have both problems with too much water sometimes, too little water, but also polluted water, so we need to act." The goal for the Commissioner is to have clean and affordable water for everybody including industry and farmers. "We need to be smarter on using water. How can we be more efficient? And then it's also about innovation and how can we use the techniques." The quality of water is another major issue facing the Commission. The presence of per- and polyfluoroalkyl substances (PFAS), also known as 'forever chemicals,' have been accumulating across EU waters for decades, posing a serious risk to human health and the environment. The European Commission says it's preparing to support a major clean-up initiative set to begin in 2026. The Commission also says it's working towards an eventual ban on the use of PFAS when it comes to consumer products including pizza boxes, cosmetics, rain clothes or firefighting foams. But it becomes much more difficult for medical products like inhalers, surgical equipment or items where there is no suitable alternative. "We need to discuss both how industries that need it can use it safely, and how we can protect it from leaking into nature or otherwise harming people's health," Roswall said. "We are working on both, how to use it in a sustainable way if you may say but we need also at the same time work on how to clean up." The Commissioner firmly believes that the "green transition and competitiveness is not contradictory." She thinks the solution lies through dialogue, including industry, NGOs and member states. The PFAS actions are intended to complement ongoing efforts to review the EU's REACH framework, which oversees EU regulation of chemicals. The revised text could come by the end of the year, following several postponements. Roswall denies accusations from environmental and consumer groups that the Commission is prioritising the demands of industry over the environment. "When we see the chemical industry, which is an important industry for all other industries, that is true because other industries need the products and we need an industry here in Europe, that is important for all of us." Roswall said she believes it's possible to support the environment and also relieve the burden on farmers when it comes to regulations. "If we don't have nature, we don't have farming—and of course, the opposite is also true. So, I would say that we are working toward the same goal. When it comes to simplification, for me, it's really about reporting. For example, I know we're focusing on how we can make it easier for farmers to report less." When discussing the needs of tackling the collapse of biodiversity, Roswall says she is pushing for a dialogue between farmers and NGOs which she says is key in understanding each other's perspectives. She suggests nature credits - financial instruments that can be traded or used to offset biodiversity impacts - would boost private sector investment and biodiversity conservation. "I would still argue that this is something that we need to do and we know that we want to do it, but we need to be smarter when we do it," she said.